CAH NYSE Week ended 24 Jul 2026

Weekly Investor Report

Cardinal Health Inc · Healthcare · Medical Distribution

Open interactive chart View report data Download investor PDF
Latest close 228.0 USD
-0.2% latest week
Weekly setup

Mixed setup

The weekly trend is active. Price is 6.6% above the Trend Line and sits at 85.8% of its 52-week range. The latest completed week returned -0.2%, after a -3.9% four-week move. The latest factor snapshot indicates quality ranks weakly versus its universe; growth is moderate; valuation is neither clearly cheap nor expensive. Options positioning is mixed with 40/100 conviction, while the latest news-sentiment score is 58/100. Near-term considerations: volume confirmation is below normal; earnings are due in 13d.

Setup score 60 out of 100
Latest Close 228.0 USD 24 Jul 2026
1W Return -0.2% latest completed week
4W Return -3.9% short-term follow-through
12W Return 17.0% quarterly tape
Trend Breadth 86.5% 45 of 52 weeks active
Volume Ratio 0.8x vs 13-week average
What is working
  • The trend backdrop is active with a 5-week active streak.
  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Price is above Fair Value, showing premium demand versus the model.
  • Activity pressure is positive on the latest completed week.
What could go wrong
  • 11 reversal markers appear in the recent smart-money tape.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through -0.2% Latest completed week; four-week move -3.9%. Indicator stack 65/74 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. Next-Week Expectancy Positive 57.85% Historical one-week expectancy contributes to the evidence score when direction is confirmed. Options pressure Mixed 40/100 conviction; expected move 3.1%. News sentiment 58/100 43 relevant articles in the latest sentiment read. Event risk 13d Next report is scheduled for 11 Aug 2026; event risk rises as the date approaches.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is active. Price is 6.6% above the Trend Line and sits at 85.8% of its 52-week range. The latest completed week returned -0.2%, after a -3.9% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 0.8x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
30 Jan 6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.6412-week average 0.50

12-week confirmation

Trend active5/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure5/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership7/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.64Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers1111 reversal markers

No recent accumulation markers. 11 reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is -3.9% over four weeks, 17.0% over 12 weeks, and 46.3% over one year. The current trend has remained active for 5 consecutive weeks.

Performance by holding period

1W-0.2%
4W-3.9%
12W17.0%
26W9.7%
52W46.3%
Active trend streak5 weeks
Active weeks in one year45
Trend breadth86.5%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure0.69Latest activity-pressure read.
Pressure change146.5%Four-week change in activity pressure.
Leadership7.74Latest relative-leadership reading.
RS change-49.8%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality ranks weakly versus its universe; growth is moderate; valuation is neither clearly cheap nor expensive.

Open full factor analysis
Factor week 26 Jul 2026 Financial statements through 30 Jun 2025 Field coverage 94% Model confidence 90%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength33/100Blend of value, momentum, and quality. Underlying universe rank 68; rank 1 is best.
Value33/100Relative valuation strength. Underlying universe rank 68; rank 1 is best.
Quality17/100Profitability and accounting quality. Underlying universe rank 84; rank 1 is best.
Momentum85/100Medium-term price momentum. Underlying universe rank 16; rank 1 is best.
Growth67/100Revenue and earnings growth. Underlying universe rank 34; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
34.3x
Price divided by trailing earnings.
Price / sales
0.2x
Market value relative to trailing revenue.
EV / EBITDA
19.3x
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
9.6%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
3.7%
Gross profit retained from each unit of revenue.
Operating margin
0.9%
Operating profit retained from revenue.
Free-cash-flow margin
2.2%
Free cash flow generated from revenue.
Return on invested capital
78.1%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
12.8%
Latest one-year revenue growth.
EPS growth
0.1%
Latest one-year earnings-per-share growth.
Free-cash-flow growth
62.8%
Latest one-year free-cash-flow growth.
Piotroski F-score
6/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
0.9%
Cash dividends relative to market value.
Buyback yield
1.9%
Net share repurchases relative to market value.
Shareholder yield
2.8%
Dividend yield plus net buyback yield.
Net debt / EBITDA
1.6x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Options positioningMixed

CAH shows mixed options pressure with a 40/100 conviction score, put-call volume ratio of 0.75, expected move of 3.1%, and Sharemaestro trend signal active.

Conviction40/100
Expected move3.1%
Put/call volume0.75
Pressure18
Speculation40
Volatility37
Trend agreement76
Open options detail
Insider activity1 / 0

1 acquisitions and 0 disposals in the latest 180-day insider tape.

Acquisitions / disposals over the latest 180 days. Insider activity is context, not a stand-alone signal.
News sentiment58/100

Weighted news tone is neutral across 43 relevant articles.

22 positive · 17 neutral · 4 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings13dNext report is scheduled for 11 Aug 2026; event risk rises as the date approaches.
Options expected move3.1%Nearest-chain priced movement where available.
52-week drawdown-6.2%Distance below the 52-week high.
13-week volatility4.3%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher12 of 2614 weeks finished lower.
Best week+8.8%Week of 12 Jun.
Worst week-6.6%Week of 24 Apr.
Latest week-0.2%Week of 24 Jul.

Shape of recent returns

Strong gains5
Modest gains7
Flat weeks0
Modest losses10
Sharp losses4
Recent vol4.3%13-week weekly-return volatility.
Base vol4.2%52-week weekly-return volatility.
Up/down split28/24Count of positive and negative weeks in the 52-week window.
Average skew3.5% / -2.4%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape61/100

Trend, activity pressure, participation, and risk combine to a 61/100 tape read.

 Indicator analysis42/100

Latest 12-week confirmation: trend 5/12, activity pressure 5/12, relative leadership 7/12.

Activity pressure 0.64; 11 reversal markers Next-Week ExpectancyPositive 57.85%

Next-week expectancy is positive with a 57.85% historical one-week setup read.

Adds short-term historical context without overriding trend, activity, or relative leadership. Factors39/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 24 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Options55/100

CAH shows mixed options pressure with a 40/100 conviction score, put-call volume ratio of 0.75, expected move of 3.1%, and Sharemaestro trend signal active.

Mixed · Options-market disagreement · Expected move 3.1% Sentiment58/100

Weighted news tone is neutral across 43 relevant articles.

Why Cardinal Health (CAH) Outpaced the Stock Market Today Insiders1 / 0

1 acquisitions and 0 disposals in the latest 180-day insider tape.

 Earnings13d

Next report is scheduled for 11 Aug 2026; event risk rises as the date approaches.

 Research flow1 items

1 recent research articles and 0 Market Watch posts are available.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
24 Jul 2026228.0 USD-0.2%213.9 USD140.3 USD0.697.749.1MOn
17 Jul 2026228.5 USD-3.1%213.2 USD139.4 USD0.907.7812.4MOn
10 Jul 2026235.8 USD-1.3%212.3 USD138.5 USD0.849.8914.5MOn
3 Jul 2026238.9 USD0.6%211.0 USD137.6 USD0.7013.287.0MOn
26 Jun 2026237.4 USD7.3%209.7 USD136.6 USD0.2815.4313.1MOn
19 Jun 2026221.3 USD-0.9%208.8 USD135.7 USD-0.345.4311.9MOff
12 Jun 2026223.4 USD8.8%208.4 USD134.8 USD-0.727.5613.6MOff
5 Jun 2026205.3 USD4.5%207.7 USD133.9 USD-1.10-0.389.0MOff
29 May 2026196.4 USD-1.9%207.7 USD133.1 USD-1.09-6.958.4MOff
22 May 2026200.2 USD2.8%207.4 USD132.4 USD-1.00-3.7510.6MOff
15 May 2026194.8 USD6.3%206.1 USD131.6 USD-1.04-5.5314.5MOff
8 May 2026183.3 USD-5.9%204.8 USD130.9 USD-1.00-10.9114.4MOff
1 May 2026194.8 USD-2.5%203.9 USD130.2 USD-1.00-3.1512.0MOn
24 Apr 2026199.8 USD-6.6%202.6 USD129.5 USD-1.000.338.3MOn
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.